Portrait of Gallagher, Michael John

Gallagher, Michael John

U.S. Representative WI-8 Republican Party

Congressional stock trade history disclosed under the STOCK Act, as filed.

Disclosed trades
38
Buys / sells
0% / 100%
Last trade
Mar 25, 2021
Last filing
Apr 6, 2021

Latest disclosed trades

Latest 10 of 38
Ticker Type Traded
WMT Sell Mar 25, 2021
DCI Sell Jan 31, 2020
FMCMF Sell Jan 13, 2020
PFE Sell Jan 13, 2020
SHW Sell Jan 13, 2020
JNJ Sell Jan 13, 2020
MRK Sell Jan 13, 2020
DCI Sell Jan 13, 2020
AAPL Sell Jan 13, 2020
MSFT Sell Jan 13, 2020

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window.

Gallagher, Michael John stock trade activity

FilingIQ has indexed 38 congressional stock trade disclosures for Gallagher, Michael John. The most recent disclosed transaction is dated Mar 25, 2021.

Across the full history, 0 purchases and 38 sales have been disclosed under the STOCK Act.

Top tickers traded by Gallagher, Michael John

Frequently asked

How many stock trades has Gallagher, Michael John disclosed?
FilingIQ tracks 38 Periodic Transaction Report disclosures for Gallagher, Michael John, with the most recent dated Mar 25, 2021. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Gallagher, Michael John a net buyer or net seller?
Across the disclosed trade history, 0 (0%) were purchases and 38 (100%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Gallagher, Michael John come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.